<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="1221">
  <stage>Registered</stage>
  <submitdate>19/04/2006</submitdate>
  <approvaldate>20/04/2006</approvaldate>
  <actrnumber>ACTRN12606000136505</actrnumber>
  <trial_identification>
    <studytitle>Vasoactive peptides: regional plasma concentrations and correlation with cardiac haemodynamic status.</studytitle>
    <scientifictitle>An observational study of the regional concentrations of vasoactive neurohormones in patients with cardiovascular disease, and their assocation with concurrent haemodynamic status.</scientifictitle>
    <utrn />
    <trialacronym>GRADIENT study</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Cardiovascular disease</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>This is a cross-sectional and observational study.  Regional transorgan arterial and venous blood sampling during diagnostic and interventional coronary angiography will be performed. Plasma will be assayed for neurohormones.  Results will be correlated with invasive haemodynamic measures taken at the time of the angiogram.</interventions>
    <comparator>No comparator.</comparator>
    <control />
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>To document the regional plasma concentrations of vasoactive peptides (including natriuretic peptides, angiotensin II, aldosterone and urocortin 1) in individuals with a spectrum of cardiovascular disease at a single time point.</outcome>
      <timepoint />
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>To document the transcardiac gradient of vasoactive neurohormones across a spectrum of cardiac and renal function at a single time point.</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1) Individuals requiring diagnostic or interventional coronary angiogram.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>:1) Clinical contraindication to invasive coronary angiographic or percutaneous procedures2) Hypotension (systolic blood pressure&lt;100mmHg)3) Anuria4) Requirement for emergency percutaneous intervention where obtaining research samples might delay treatment.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>31/03/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Professor Mark Richards, Professor in Medicine, Christchurch School of Medicine and Health Sciences</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Christchurch Cardioendocrine Research Group</fundingname>
      <fundingaddress />
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Health Research Council of New Zealand</fundingname>
      <fundingaddress />
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>Christchurch School of Medicine and Health Sciences</sponsorname>
      <sponsoraddress />
      <sponsorcountry>New Zealand</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>In 100 individuals with known or suspected heart disease we propose to describe the trans-cardiac (ie difference between circulation supplying heart and draining heart) and trans-organ (ie across the circulation of an organ) gradients of an array of circulating proteins of known and potential significance in heart disease.  The study will determine whether these proteins are formed or eliminated by each organ studied and extend the knowledge of the metabolism of these proteins within the body.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Chirstchurch School of Medicine and Health Scieinces</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>New Zealand Upper South B Regional Ethics Committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec>URB/06/02/010</hrec>
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Suetonia Palmer</name>
      <address>Department of Medicine
Christchurch School of Medicine and Health Sciences
PO Box 4345
Christchurch</address>
      <phone>+64 3 3641116</phone>
      <fax>+64 3 3641115</fax>
      <email>suetoniapalmer@clear.net.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Suetonia Palmer</name>
      <address>Department of Medicine
Christhcurch School of Medicine and Health Sciences
PO Box 4345
Christchurch 8001</address>
      <phone>+64 3 3640496</phone>
      <fax>+64 3 3641115</fax>
      <email>suetoniapalmer@clear.net.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>